The richest man starts with black technology

Chapter 189

(I came back late, there are two hundred words repeated, and the typo is not changed. Wait fifteen minutes.)

Hopkins University, medical school meeting room.

Medical experts from major universities across the country and representatives of hospitals and clinics gathered here, and the expressions on everyone's faces were very solemn.

This time they talked about not only academic topics but also business topics-the impact of symbiotic proteins, digestive bacteria on the global medical field, and the outflow of high-end U.S. medical services.

The reason why Xia Guo’s medical travel project is banned is because Xia Guo’s Origin Technology has achieved technological monopoly in some medical fields and has already touched the cake in the US medical field. This is completely unbearable.

In the past, the United States has always monopolized global medical resources. Not only Americans will be treated in their own country, but many patients around the world will go to the United States for treatment, and American anticancer drugs are also sold around the world.

Medical care in the United States is not about saving the dead, but a business.

How profitable is this business?It can absorb all the savings of a middle class, hundreds of thousands of meters of knives are small sums, some Xia people go to the United States for treatment, and millions of meters of knives can be spent.

Johnsen, an expert in respiratory medicine at the Mayo Clinic, has a set of data from their hospital. He said: “Take lung cancer as an example. There were more than 100 patients who were hospitalized and operated on in our hospital last month, but now there are fewer than 30. We followed up and investigated some patients, and they all went to Xiaguo for treatment. Even some lung cancer patients would choose to go to Xiaguo for resection surgery and then symbiotic protein treatment."

Johnson said: "If the artificial digestive system is used clinically, the number of critically ill patients in our gastroenterology department may be reduced by half immediately."

Johnson reluctantly criticized Hopkins's behavior this time: "Even if the court imposed a medical travel ban, for our patients, the ban is a piece of waste paper. Patients will Try all kinds of ways to go to Xia Country, or transfer to Xia Country through Lion City, South Korea and other places. What they told was to travel and do business investigations, but not to treat the disease. We did not have any legal means to remove patients from Pull back to the airport."

Johnson grasped the core of the problem: "The core question now is, can we master the technology of symbiotic proteins and digestive bacteria?"

Professor Hadley from Stanford University said: "Symbiotic protein and digestive bacteria technology have created a new world for the global medical field, but it is a pity that our laboratory cannot repeat the experiments of origin technology. Here at Hopkins University It's so impulsive! Do you know what people outside say? It is said that Hopkins University is sending money to Origin Technology."

Hadley said: "Our laboratory once studied a patient who was transplanted with a symbiotic protein, but got nothing. Three years ago, I couldn't imagine that Xia Guo's medical field would develop to such a high level."

"We just want to know the answer to one question. Has Hopkins University already mastered the technology of digesting bacteria?"

The representative of Hopkins University, Professor Middle, said with an embarrassed face and said: "It is true that we have not yet mastered this technology at this position."

As soon as these words came out, the medical elites sitting in the conference room couldn't sit still and started talking in a noisy manner.

"The key link in the current problem is not whether we can prevent patients from going to Xia, but whether we have the technology to keep patients in the United States."

"This matter cannot be measured by money. After all, the number of patients we have lost is a small number, and there are only a few thousand people in the United States. But in the long run, we will lose the leading position in academics and medicine. If one day, Origin Technology develops the right Cancer has special effects, what should I do then!"

Can't let Origin Technology develop!

This is the consensus of the American medical community.

But the most urgent task now is to find a way to figure out the principle and development process of symbiotic proteins and digestive bacteria.

Send someone to Xia Country!

You can only send people to Xia Country to study in Origin Technology.

The medical circles in the U.S. never expected that they would send someone to Xia to learn medical knowledge.

If anyone said this five years ago, they would laugh off the big teeth of American academic circles.

Sending people to Xia to learn knowledge is certainly not an honest study. The medical community in the U.S. will cooperate with relevant departments and use all resources to explore the intelligence information of symbiotic proteins and digestive bacteria.

...

In Jiangcheng, Xu Yang met Zhou Xiao after a long journey and brought good news.

"Mexico agrees that we will cooperate with local hospitals to establish a treatment center for respiratory medicine and gastroenterology in Mexico City."

Xu Yang introduced the situation of negotiations with Mexico.

Mexico's willingness to cooperate with Origin Technology is mainly based on economic considerations.

Mexico is very close to the United States, but public security is chaotic and the domestic economic development is also very tired.

They are eager to negotiate business with foreign companies, and they are eager to earn rice knives.

Moge City is one of the better public security cities in Mexico, and it is also one of the cities with a relatively concentrated elite.

The establishment of the treatment center is a win-win situation for Moguo and Origin Technology.

The specific cooperation model of the treatment center is a little more complicated than Xia Guo's domestic cooperation model.

Origin Technology provides a training medical team in Mexico City Hospital for a long time, that is, training the local medical staff of the hospital